Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Pharmaceuticals
Pharmaceuticals
by calandra-battersby
HSPM J712. 11/10/2010. What is the real product o...
Phase I trials: A New era in
Phase I trials: A New era in
by mitsue-stanley
OnCology. drug development. Jan 22, 2015. Method...
Stephen A. Bean, PharmD
Stephen A. Bean, PharmD
by lois-ondreau
Investigational Drug Service. Department of Pharm...
Illuminating
Illuminating
by trish-goza
the Fine Print: . Visualizing . Medication . Side...
Rationale for New Drugs for Tuberculosis
Rationale for New Drugs for Tuberculosis
by pamella-moone
500,000 cases annually of MDR TB. Second line tre...
Drug Prescribing For Dentistry
Drug Prescribing For Dentistry
by liane-varnes
Clinical Effectiveness ProgrammeSDcep Drug Prescri...
Lessons Learned from Sovaldi -
Lessons Learned from Sovaldi -
by tawny-fly
The Future is NOW in Specialty Pharmacy. August, ...
Survival Analysis for Randomized Clinical Trials
Survival Analysis for Randomized Clinical Trials
by celsa-spraggs
Ziad. . Taib. March . 3, 2014. I The log-rank te...
Herbal Drug Regulation
Herbal Drug Regulation
by phoebe-click
02-Jun-2011. What is traditional medicine?. WH...
Managing Data and Projects Across the Globe
Managing Data and Projects Across the Globe
by louie378
University of Massachusetts Software Engineering....
Background Questions Answers Academy Janina Karres Scientific Officer
Background Questions Answers Academy Janina Karres Scientific Officer
by nelson
the meeting). EURORDIS . Open Academy . 05 June 20...
Cardiovascular Monitor Technician
Cardiovascular Monitor Technician
by makai172
at . BCCC. YOU BELONG HERE. What is a Cardiovascul...
CERTIFICATION EXAM PREPARATION COURSE
CERTIFICATION EXAM PREPARATION COURSE
by ezrah
SESSION 8. Handout/Reference sheets:. Study Start-...
Late Breaking (NAF) News
Late Breaking (NAF) News
by amber
What can we accomplish with more than 2X revenue a...
UpToDate UpToDate is an electronic evidence-based clinical decision support tool written by physici
UpToDate UpToDate is an electronic evidence-based clinical decision support tool written by physici
by harper
Answer clinical questions. Update clinical knowled...
Pharmacometrics and Biostatistics Interactions at the FDA
Pharmacometrics and Biostatistics Interactions at the FDA
by byrne
Jeffry Florian, Ph.D.. Division of Pharmacometrics...
Internship at Inclin Kelly Speth
Internship at Inclin Kelly Speth
by margaret
November 4, 2013. My Background & Experience. ...
Decentralized Trials: Regulatory and Implementation Issues
Decentralized Trials: Regulatory and Implementation Issues
by jaena
C. Karen Jeans, . PhD, CCRN, CIP. VHA Office of Re...
AI for Smarter Healthcare
AI for Smarter Healthcare
by roberts
and Clinical. Research. INTELLIGENCE. IN CLINICAL ...
Invex Therapeutics  Bell Potter Healthcare Conference
Invex Therapeutics  Bell Potter Healthcare Conference
by gabriella
26 November 2020. ASX Code: . IXC. Disclaimer. Thi...
RESPONSE TO RFP Assays for treatment monitoring in tuberculosis drug studies
RESPONSE TO RFP Assays for treatment monitoring in tuberculosis drug studies
by bethany
Applicant Name. Address. Contact Information . Ove...
Session 8: Study Start-up: Part 2
Session 8: Study Start-up: Part 2
by gabriella
Derita: . dbran@uthsc.edu. Margaret: . mlynn@ut...
The (frequently long, circuitous, and
The (frequently long, circuitous, and
by jaena
bumpy) trip from clinical problems to clinical tri...
How a Hospital Biobank Supports Patient Care and Research Programs
How a Hospital Biobank Supports Patient Care and Research Programs
by ceila
National Cancer Center Hospital. Tokyo, Japan. Oct...
GUR-701 (Regeus®) Potential blockbuster drug for
GUR-701 (Regeus®) Potential blockbuster drug for
by teresa
. hair loss. Key 8 facts. GUR-701 has got Clinical...
Challenges in Assessing Therapeutic Equivalence of
Challenges in Assessing Therapeutic Equivalence of
by thomas
Nanosimilars. Beat . Flühmann. Global Lead NBCD ....
1 Immunogenicity The key safety issue for biosimilars
1 Immunogenicity The key safety issue for biosimilars
by gelbero
Prof. Ibrahim A. . Alsarra. Professor . of . Phar...
Striking the Balance: FDA Oncology’s Regulatory Perspective on Development of Agents for CIPN
Striking the Balance: FDA Oncology’s Regulatory Perspective on Development of Agents for CIPN
by rodriguez
Lynn Howie, MD, Medical Officer, DOP1. Supportive ...
Writing and Holding an IND- IIT Development
Writing and Holding an IND- IIT Development
by osullivan
Week 3- Proposing and Conducting a Clinical Trial....
Session I: DHT-Derived Novel Endpoint Development: Current Landscape
Session I: DHT-Derived Novel Endpoint Development: Current Landscape
by deborah
Elektra Papadopoulos, . FDA/CDER. Lindsay Kehoe, ....
Tanni AZ Uddin MF Arafat SM Selim S Mustari M et al 2022 Glime
Tanni AZ Uddin MF Arafat SM Selim S Mustari M et al 2022 Glime
by beatrice
The Syndrome of Inappropriate Antidiuretic Hormone...
E2A Document History
E2A Document History
by danya
First Codification History Date New Codificatio...
REVIVING THE PIPELINE OF LIFESAVING ANTIBIOTICS
REVIVING THE PIPELINE OF LIFESAVING ANTIBIOTICS
by miller
EXPLORING SOLUTIONS TO SPUR INNOVATION Conference ...
This guidance document is being distributed for comment purposes only
This guidance document is being distributed for comment purposes only
by carla
15028dft.doc 07/27/16 Additional copies are availa...
Deciding to Participate in Research
Deciding to Participate in Research
by jasmine
The Pros and Cons. Natalie Diaz, MD. Pacific Neuro...
J. Mehilli, MD , G. Richard, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache,
J. Mehilli, MD , G. Richard, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache,
by berey
J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim, A. S...
Managing Ataxia: Soup to nuts
Managing Ataxia: Soup to nuts
by pagi
Susan L. Perlman M.D.. Clinical Professor of Neuro...
Cerebellar ataxia research update
Cerebellar ataxia research update
by ximena
Dr Julie Vallortigara. Forward with Hope . Overvie...
Engaging professional societies in improving the quality of
Engaging professional societies in improving the quality of
by everly
care . A . view from the ACP. Steven Weinberger, M...
Preparing for an FDA Inspection
Preparing for an FDA Inspection
by felicity
. Kathy Gilmartin, MSN, CRNP, CCRC. ...